Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Spangenberg Shibley & Liber's $2.7 Million Verdict Affirms Patient’s Right to Know
  • USA - English


News provided by

Spangenberg Shibley & Liber

Feb 04, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Medical Malpractice Attorney Peter Weinberger (Left), and Mrs. Neifer's husband, Mark (Right).
Medical Malpractice Attorney Peter Weinberger (Left), and Mrs. Neifer's husband, Mark (Right).

Cleveland, Ohio (PRWEB) February 04, 2014 -- Medical Malpractice Attorney Peter H. Weinberger of the Spangenberg Shibley & Liber law firm reports that a court jury in Cleveland has returned a verdict of $2,700,000 for injuries caused to Mrs. Debbie Neifer – a wife, mother and waitress at a Cleveland-area Friendly’s. (Case: CV 12 787443 in Cuyahoga County Court of Common Pleas)

The horrific injuries suffered by Mrs. Neifer that ultimately led to her death a month after the verdict could have been avoided had her doctor exercised the appropriate standard of care. -Peter Weinberger

Post this

According to court documents, in March of 2006, Mrs. Debbie Neifer sought treatment with Dr. Carlos Zevallos for her rheumatoid arthritis. At that first visit, Dr. Zevallos increased her dosage of Methotrexate (a commonly prescribed Disease Modifying Anti-Rheumatic Drug) that her primary care physician had prescribed and ordered a chest x-ray, which was clear, showing no pulmonary disease.

According to court documents, in 2010, she returned to Dr. Zevallos, who decided to supplement the Methotrexate she was taking with the drug Leflunomide. While Methotrexate and Leflunomide can be used in combination to provide greater relief than either drug alone in some patients, the drugs when taken together have the potential to cause severe lung disease, especially in patients like Mrs. Neifer. Notwithstanding that risk, Dr. Zevallos added the Leflunomide and did not order tests to evaluate her lungs. Just seven months later, at a regularly-scheduled appointment, Dr. Zevallos heard crackling in Mrs. Neifer’s lungs during a routine office visit. Dr. Zevallos sent her for a chest x-ray. The following day, Dr. Zevallos received the x-ray results with comments from the radiologist indicating possible lung disease. In fact, had further testing been done at that time, it would have been discovered that Mrs. Neifer was now suffering from interstitial lung disease - a known risk of combing Methotrexate and Leflunomide. However, Dr. Zevallos did nothing to follow up on the x-ray and further, he failed to inform Mrs. Neifer of the abnormal x-ray result, preventing her from appropriately participating in decisions regarding any future course of treatment. All Dr. Zevallos did was file the x-ray report in her chart and continue to prescribe Methotrexate and Leflunomide.

According to court documents, in June 2011 - nine months after the abnormal chest x-ray – Mrs. Neifer was having trouble breathing and was rushed to the emergency room. She learned then that she had developed terminal lung disease, caused by the combination of Methotrexate and Leflunomide. She spent months in the hospital, away from her family, unable to work. She moved to a nursing home, where she was confined to a wheelchair, requiring an increasing supply of external oxygen in order to breath. A month after the verdict, on January 18, 2014, Mrs. Neifer passed away from her injuries, leaving behind her husband Mark and son Michael.

Mrs. Neifer incurred medical bills in excess of $650,000. She was totally and permanently disabled and required round the clock care and oxygen treatment before she died. The jury awarded her $1,000,000 for her economic losses, $1,000,000 for her non-economic losses, and her husband $700,000 for his losses.

Many of Spangenberg Shibley & Liber LLP's cases come via word-of-mouth, either from satisfied former clients or from other attorneys who know the firm is skilled at handling the complex litigation required for their cases. The Spangenberg law firm has consistently proven itself a worthy partner in co-counsel arrangements on a range of cases and willingly accepts any challenges after carefully analyzing the merits of the case. Though the firm has certainly proven its ability with products liability and has some of the best Cleveland personal injury lawyers, it is equally adept in assisting businesses and corporations with the issues that they have involving business disputes and insurance claims.

The Cleveland attorneys of the Spangenberg, Shibley & Liber Ohio Law Firm have devoted themselves to representing injured persons and aggrieved businesses for more than sixty-five years. They are headquartered at 1001 Lakeside Avenue East, Suite 1700, in Cleveland, Ohio 44114. For more information, you are invited to visit them online at: http://www.Spanglaw.com.

Barbara Andelman, Spangenberg Shibley & Liber, http://www.spanglaw.com, 216-696-3232, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.